来自专业的译者、企业、网页和免费的翻译库。
tirkadi u tbatti
85% (37%)
最后更新: 2011-10-23
使用频率: 1
质量:
警告:此对齐可能有误。
如果您觉得是这样,请将其删除。
qisu qed terġa tirkadi.
a relapse.
最后更新: 2011-10-23
使用频率: 1
质量:
警告:此对齐可能有误。
如果您觉得是这样,请将其删除。
sklerożi multipla li tirkadi
relapsing multiple sclerosis
最后更新: 2017-04-26
使用频率: 2
质量:
sklerożi multipla li tirkadi u tbatti
relapsing- remitting multiple sclerosis
最后更新: 2017-04-26
使用频率: 3
质量:
sklerożi multipla li tirkadi u tbatti:
in this leaflet:
最后更新: 2011-10-23
使用频率: 1
质量:
警告:此对齐可能有误。
如果您觉得是这样,请将其删除。
sklerożi multipla li tirkadi-tbatti (rr-ms)
relapsing-remitting multiple sclerosis (rr-ms)
最后更新: 2017-04-26
使用频率: 1
质量:
pazjenti dijanjostikati bi sklerosi multipla (ms) li tirkadi.
patients diagnosed with relapsing multiple sclerosis (ms).
最后更新: 2017-04-26
使用频率: 3
质量:
tortikollis (tirkadi mil-linja bażi), perverżjoni tat-togħma
torticollis (worsening from baseline), taste perversion
最后更新: 2017-04-26
使用频率: 1
质量:
tecfidera jintuża għal kura ta’ sklerożi multipla (ms) li tirkadi u tbatti.
tecfidera is used to treat relapsing-remitting multiple sclerosis (ms).
最后更新: 2017-04-26
使用频率: 1
质量:
rebif hu indikat għall-kura ta’ pazjenti bi sklerożi multipla li terġa tirkadi.
rebif is indicated for the treatment of relapsing multiple sclerosis.
最后更新: 2017-04-26
使用频率: 3
质量:
eżatt wara injezzjoni l-muskoli tiegħek jistgħu jinħassu stirati jew dgħajfa ħafna – bħal qisu qed terġa tirkadi.
just after an injection, your muscles may feel tense or very weak – as though you are having a relapse.
最后更新: 2017-04-26
使用频率: 1
质量:
għal sklerożi multipla li tirkadi u tbatti l-effikaċja tat-terapija ġiet murija għall-ewwel sentejn.
for relapsing-remitting ms, efficacy has been demonstrated for therapy for the first two years.
最后更新: 2017-04-26
使用频率: 3
质量:
pazjenti bi sklerożi multipla li tirkadi u tbatti b’żewġ episodji ta’ rkadar jew iktar fl-aħħar sentejn.
patients with relapsing remitting multiple sclerosis and two or more relapses within the last two years.
最后更新: 2017-04-26
使用频率: 3
质量:
l-analiżi miġbura kkontrollata bi plaċebo ġiet ibbażata fuq 2047 pazjent bi sklerożi multipla li tirkadi, ikkurati b'teriflunomide darba kuljum.
the placebo-controlled pooled analysis was based on 2047 patients with relapsing multiple sclerosis treated with teriflunomide once daily.
最后更新: 2017-04-26
使用频率: 1
质量:
hemm tagħrif tal- follow-up taħt kundizzjonijiet kliniċi kontrollati għal pazjenti li għandhom sklerożi multipla li tirkadi u tbatti sa 5 snin u għal pazjenti li għandhom sklerożi multipla progressiva sekondarja sa 3 snin.
there are follow-up data under controlled clinical conditions for patients with relapsing-remitting multiple sclerosis for up to 5 years and for patients with secondary progressive multiple sclerosis for up to 3 years.
最后更新: 2017-04-26
使用频率: 3
质量:
effikaċja klinika bl-għoti taħt il-ġilda ta’ bortezomib f’pazjenti b’majeloma multipla li tirkadi/refrattorja
clinical efficacy with subcutaneous administration of bortezomib in patients with relapsed/refractory multiple myeloma
最后更新: 2017-04-26
使用频率: 1
质量:
persuni b’ ms li tirkadi u tbatti jkollhom attakki kull tant żmien jew rikaduti li matulhom is- sintomi jmorru għall- agħar b’ mod notevoli.
people with relapsing-remitting ms have occasional attacks or relapses during which symptoms become noticeably worse.
最后更新: 2011-10-23
使用频率: 1
质量:
警告:此对齐可能有误。
如果您觉得是这样,请将其删除。
għall-pazjenti bi sklerożi multipla li tirkadi u tbatti hemm tagħrif meħud wara l-bidu tal-kura taħt kundizzjonijiet kliniċi kkontrollati sa 5 snin u għal pazjenti bi sklerożi multipla progressiva sekondarja hemm tagħrif sa 3 snin.
there are follow-up data under controlled clinical conditions for patients with relapsing-remitting ms for up to 5 years and for patients with secondary progressive ms for up to 3 years.
最后更新: 2017-04-26
使用频率: 3
质量: